BrandPilot AI Converts Fortune 50 Healthcare Trial into Ongoing Customer Engagement
Rhea-AI Summary
BrandPilot AI (CSE: BPAI, OTCQB: BPAIF) announced that its previously disclosed Fortune 50 U.S. healthcare customer has moved from a paid trial of the AdAi platform to an ongoing commercial engagement, now executed through the customer's existing media agency partner and workflows.
The new agreement is ongoing and may be terminated by either party under its terms. It is performance-based, with no fixed contract value; revenue will depend on advertising savings generated using BrandPilot's technology. During the trial, AdAi reduced average cost-per-click by about 33% period-over-period while maintaining campaign performance. BrandPilot views agency-enabled enterprise deployments as a key element of its long-term commercial strategy alongside direct enterprise relationships.
Positive
- Fortune 50 healthcare trial converted into ongoing commercial engagement
- AdAi cut average cost-per-click ~33% during trial while maintaining performance
- Ongoing, agency-enabled deployment embeds platform into existing enterprise workflows
- Performance-based model aligns BrandPilot revenue with measurable advertising savings
Negative
- Engagement has no fixed contract value, creating variable and uncertain revenue
- Commercial agreement is terminable by either party, limiting long-term visibility
AI-generated analysis. How Rhea-AI works. Not financial advice.
Previously Announced Trial Advances into Ongoing Customer Relationship Through Agency Partner
Toronto, Ontario--(Newsfile Corp. - July 30, 2026) - BrandPilot AI Inc. (CSE: BPAI) (OTCQB: BPAIF) ("BrandPilot" or the "Company"), a provider of AI-powered advertising performance technology focused on reducing fraud, waste and abuse in digital advertising, today announced that its previously disclosed Fortune 50 healthcare customer has transitioned from a paid trial into an ongoing commercial engagement.
As previously announced on February 24, 2026, the Company commenced a paid trial with a Fortune 50 U.S. healthcare organization. Following the successful evaluation of BrandPilot's AdAi platform, the customer elected to continue the relationship through its media agency partner, allowing deployment through the customer's existing agency workflows.
The commercial agreement is ongoing in nature and will remain in effect unless terminated by either party in accordance with its terms. Consistent with BrandPilot's business model, the engagement is performance-based and does not include a fixed contract value. Revenue earned by the Company will depend on advertising savings generated through the use of its technology.
During the trial period, BrandPilot's AdAi platform reduced average cost-per-click by approximately
"We're pleased to see another enterprise evaluation convert into an ongoing commercial relationship," said Brandon Mina, Chief Executive Officer of BrandPilot AI. "Large organizations often validate new technologies through limited trials before integrating them into existing agency and procurement workflows. We believe this progression reflects the value we deliver and the increasing demand for technologies that improve advertising efficiency."
Seif Khemaissia, Chief Growth Officer of BrandPilot AI, added:
"Enterprise advertisers continue to prioritize measurable performance improvements before expanding technology investments. Converting paid trials into ongoing customer relationships demonstrates that our platform is addressing a meaningful need for greater efficiency and accountability in digital advertising."
The Company believes agency-enabled enterprise deployments represent an important component of its long-term commercial strategy, allowing BrandPilot to support enterprise organizations through both direct customer relationships and agency partners.
About BrandPilot AI
BrandPilot AI (CSE: BPAI) is a performance marketing technology company headquartered in Toronto, focused on identifying and eliminating inefficiencies in digital advertising for global enterprise brands. The Company's core capabilities include AdAi, which eliminates cannibalistic branded search spend that inflates costs without driving incremental value; ClickRadar™, which compiles forensic bot-detection reports to reclaim refunds associated with invalid traffic; and SearchIQ™, which enables brands to measure and optimize their presence across generative AI search platforms.
BrandPilot is purpose-built to address structural challenges in modern digital advertising, where increasing automation and scale can reduce transparency and accountability. Operating as an independent performance and validation layer, the Company helps enterprises recover wasted budgets, restore data integrity, and gain clearer visibility into how advertising dollars are spent so performance can be improved with greater confidence.
CONTACT INFORMATION
BrandPilot AI
Brandon Mina
Chief Executive Officer
+1-888-960-2724
ir@brandpilot.ai
Forward Looking Statements
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the business of BrandPilot AI Inc. ("BrandPilot" or the "Company"). Any such forward-looking statements may be identified by words such as "expects," "anticipates," "believes," "projects," "plans," "intends," "may," "will," and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements regarding, among other things, the continued deployment of the Company's AdAi platform pursuant to the commercial agreement described herein; the Company's relationship with Assembly Global and the deployment of its technology in support of Elevance Health; the Company's ability to generate revenue under its performance-based commercial model; the Company's ability to support enterprise customers through direct and agency-led channels; the advancement of its enterprise sales pipeline; the adoption of the Company's advertising performance, efficiency, and traffic quality solutions; and the Company's business strategy, growth prospects, and future commercial opportunities are considered forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those implied by such statements.
Forward-looking statements involve significant risks, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements to differ materially from those discussed or implied in the forward-looking statements, including, but not limited to: the Company's ability to successfully implement and maintain the commercial agreement described herein; the continuation of the Company's relationship with Assembly Global and the underlying customer; the realization of advertising savings that generate performance-based revenue; customer adoption and continued use of the Company's technology solutions; changes to customer advertising budgets or marketing strategies; changes to major digital advertising platforms, technologies, or policies; competitive developments within the advertising technology and artificial intelligence industries; general economic, industry, and market conditions; and the Company's ability to execute on its growth strategy. These factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon assumptions that management believes are reasonable, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company undertakes no obligation to update or revise them except as required by applicable law.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/307280